RARE 8-K 2026-10-14

Ultragenyx Pharmaceutical Inc. (RARE) 8-K dated 2026-10-14 — accession 0001193125-26-421079. This URL is the filing, not the RARE hub.

Ultragenyx Pharmaceutical Inc. (RARE) is a biotechnology company listed on US.

Ultragenyx Pharmaceutical Inc. filed a 8-K on 2026-10-14. Accession 0001193125-26-421079.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RARE revenue for 2025-12-31 was $673.0M. Net income was -$575.0M. Revenue was up 20.1% from 2024-12-31 to 2025-12-31. RARE currently screens at market cap $2.79B.

Not investment advice. The RARE SEC hub lists recent forms. The stock page is the research view.